BridgeBio Pharma, Inc.
2020 Q1 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 2,500 | 0.0% | 32,683 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 1,698 | 0.0% | 32,683 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 1,411 | 0.0% | 32,683 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 1,130 | 0.0% | 32,683 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 897 | 0.0% | 32,683 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 832 | 0.0% | 32,683 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 828 | 0.0% | 32,683 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 590 | 0.0% | 35,583 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 1,319 | 0.0% | 32,683 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 862 | 0.0% | 32,683 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 559 | 0.0% | 32,513 | 6/30/2023 |
| 2023 Q1 | 6/14/2023 | 590 | 0.0% | 35,583 | 3/31/2023 |
| 2022 Q4 | 6/14/2023 | 271 | 0.0% | 35,583 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 418 | 0.0% | 42,093 | 9/30/2022 |
| 2022 Q2 | 8/5/2022 | 382 | 0.0% | 42,093 | 6/30/2022 |
| 2022 Q1 | 5/6/2022 | 427 | 0.0% | 42,083 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 702 | 0.0% | 42,083 | 12/31/2021 |
| 2021 Q3 | 11/8/2021 | 1,972 | 0.0% | 42,084 | 9/30/2021 |
| 2021 Q2 | 8/10/2021 | 2,542 | 0.0% | 41,704 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 2,213 | 0.0% | 35,922 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 2,280 | 0.0% | 32,060 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 1,275 | 0.0% | 33,970 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 1,000 | 0.0% | 30,680 | 6/30/2020 |
| 2020 Q1 | 5/5/2020 | 447 | 0.0% | 15,400 | 3/31/2020 |